Utah Medical Products, Inc. (UTMD:NASDAQ) closed at $70.55 on November 2, 2026, up 3.64% on the day. The stock trades 8.2% below its 52-week high of $76.89 and 31.5% above its 52-week low of $53.66. Over the past year, it gained 20.6%. Utah Medical Products, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 31, 2025, UTMD closed higher on 130 days (52%). Its best day was June 26, 2026 (+10.62%) and its worst was July 23, 2026 (-7.24%). The stock moved 10% or more in a single session 1 time.
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. The company also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit. In addition, it provides LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes; other UTMD supplies and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; EPITOME, an electrosurgical scalpel; FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; holmium laser fibers; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Ca...
Find more stocks like UTMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.